Skeletal muscle tissue engineering using isolated myoblasts on synthetic biodegradable polymers: Preliminary studies

Tissue Engineering

Volumn 5, Issue 6, 1999, Pages 525-531

  Saxena, Amulya K ^a,b   Makler, Jennifer ^a   Benvenuto, Mark ^a   Willital, Gunter H ^b   Vacanti, Joseph P ^a,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DESMIN; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; BIOENGINEERING; CELL TRANSPLANTATION; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

EID: 0032787559     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.1999.5.525     Document Type: Article

References (19)

1. Duthie, R.B., and Hoaglund, F.T. Manifestations of musculoskeletal disorders. In: Principles of Surgery, 4th ed. New York: McGraw-Hill, 1984, pp. 1829-1879.
2. Rando, T.A., Pavlath, O.K., and Blau, H.M. The fate of myoblasts following transplantation into mature muscle. Exp. Cell Res. 220, 383, 1995.
3. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
4. Cima, L.G., Vacanti, J.P., Vacanti, C., Ingber, D., Mooney, D., and Langer, T. Tissue engineering by cell transplantation using degradable polymer substrates. J. Biomech. Eng. 113, 143, 1991.
5. Neville, C., Rosenthal, N., McGrew, M., Bogdanova, N., and Hauschka, S. Skeletal muscle cultures. Methods Cell Biol. 52, 85, 1997.
6. Campion, D.R. The muscle satellite cell: a review. Int. Rev. Cytol. 87, 225, 1984.
7. Hughes, S.M., and Blau, H.M. Muscle fiber pattern is independent of cell lineage in postnatal rodent development. Cell 68, 659, 1992.
8. Law, P.K., Bertoni, T.E., Goodwin, T.G., et al. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 336, 114, 1990.
9. Law, P.K., Godwin, T.G., and Wang, M.G. Normal myoblast injections provide genetic treatment for murine dystrophy. Muscle Nerve 11, 525, 1988.
10. Partridge, T.A., Morgan, J.E., Coulton, G.R., Hoffmann, E.P., and Kunkel, L.M. Conversion of mdx myofibers from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337, 176, 1989.
11. Karpati, G., Pouliot, Y., Zubrzycka-Gaam, E., et al. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am. J. Pathol. 135, 27, 1989.
12. Morgan, J.E., Huffman, E.P., and Partridge, T.A. Normal myogenic cells from newborn mice restore normal histology to degenerating muscle of the mdx mouse. J. Cell Biol. 111, 2437, 1990.
13. Gussoni, E., Pavlath, O.K., Lanctot, A.M., et al. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356, 435, 1992.
14. Dhawan, J., Pam, L.C., Pavlath, G.K., Travis, M.A., Lanctot, A.M., and Blau, H.M. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254, 1509, 1991.
15. Jiao, S., Gurevich, V.G., and Wolff, J.A. Long-term correction of rat model of Parkinson's disease by gene therapy. Nature 362, 450, 1993.
16. Yao, S.N., and Kurachi, K. Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc. Natl. Acad. Sci. U.S.A. 89, 3359, 1992.
17. Hardimann, O.D., Sklar, R.M., and Brown, R.H., Jr. Direct effects of cyclosporin A and cyclophosphamide on differentiation of normal human myoblasts in culture. Neurology 43, 1432, 1993.
18. Labreque, C, Roy, R., and Tremblay, J.P. Immune reaction after monocyte transplantation in mouse muscles. Transplant. Proc. 24, 2889, 1992.
19. White, T.P., Maxwell, L.C., Sosin, D.M., and Faulkner, J.A. Capillary and blood flow of transplanted skeletal muscle of cats. Am. J. Physiol. 241, H630, 1981.